ATM safeguards liver homeostasis by mitigating mitochondrial hypermetabolism and bioenergetic crisis in MASLD
The rising incidence of Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive stage, Metabolic dysfunction-associated steatohepatitis (MASH), represents the most prevalent chronic liver condition and a major health problem. Key molecular mechanisms driving this progression remain unclear. We demonstrate that Replication stress (RS) is a dominant hallmark across all stages of human MASLD, while an ATM-mediated DNA Damage Response (DDR) signature is specifically associated with advanced, fibrosing MASH. Using a preclinical MASLD model, we show that ATM (Ataxia-Telangiectasia Mutated) serves as a critical metabolic safeguard. Hepatocyte-specific deletion of ATM significantly worsens liver damage and fibrosis. Mechanistically, ATM-deficient MASLD hepatocytes exhibit increased oxygen consumption and accelerated TCA cycle flux, driving a metabolic surge accompanied by proton leak, ROS production and mitophagy. This mitochondrial dysfunction results in severe hepatic nucleotide pool imbalance, energy deficit and toxic lipid accumulation. Together, these findings reveal that, beyond its canonical role in DNA repair, ATM safeguards liver homeostasis by restraining mitochondrial hypermetabolism and preventing bioenergetic crisis during MASLD progression.
Authors
- Pierre Cordier
- Irene Portolés (ORCID: https://orcid.org/0000-0002-5061-0515)
- Bart Staels (ORCID: https://orcid.org/0000-0002-3784-1503)
- Hanna Kulyk (ORCID: https://orcid.org/0000-0003-2824-8115)
- Marie Lagouge (ORCID: https://orcid.org/0000-0002-3954-9207)
- Philippe Gual (ORCID: https://orcid.org/0000-0001-7393-8356)
- Maëva Saroul-Aïnama (ORCID: https://orcid.org/0000-0002-9774-1862)
- Ivan Nemazanyy (ORCID: https://orcid.org/0000-0001-8080-839X)
- Géraldine Gentric (ORCID: https://orcid.org/0000-0002-7558-8705)
- Marie Lhomme (ORCID: https://orcid.org/0000-0002-6335-4506)
- Joel T. Haas (ORCID: https://orcid.org/0000-0002-0028-5988)
- Isabelle Galy–Fauroux (ORCID: https://orcid.org/0000-0001-8477-051X)
- Solenne Marmier (ORCID: https://orcid.org/0000-0002-6671-0940)
- Sandra Lacas‐Gervais (ORCID: https://orcid.org/0000-0002-5570-4166)
- Delphine Eberlé (ORCID: https://orcid.org/0000-0003-2211-6146)
- Chantal Desdouets (ORCID: https://orcid.org/0000-0002-1955-8915)
- Floriant Bellvert (ORCID: https://orcid.org/0000-0002-3259-8655)
- Sven Francque (ORCID: https://orcid.org/0000-0002-7527-4714)
- Fatima Mechta‐Grigoriou (ORCID: https://orcid.org/0000-0002-3751-6989)
- Romain Donné (ORCID: https://orcid.org/0000-0002-8152-1283)
- Christelle Kaboré (ORCID: https://orcid.org/0000-0003-0281-0368)
- Maelle Cadiou (ORCID: https://orcid.org/0009-0005-2071-9009)
- Jean‐Pierre Couty (ORCID: https://orcid.org/0000-0003-3492-9136)
- Séverine Celton‐Morizur (ORCID: https://orcid.org/0000-0001-5622-9777)
- Alice Verdier
- Enora Le Questel (ORCID: https://orcid.org/0009-0008-8237-1572)
- Jody W. Valk (ORCID: https://orcid.org/0009-0006-7883-7064)
- Joana Gonçalves Araujo (ORCID: https://orcid.org/0009-0000-0568-477X)
- Qiyuan He (ORCID: https://orcid.org/0009-0002-6658-5761)
- Jing Fang
Institutions
- Centre National de la Recherche Scientifique (FR)
- University of Antwerp (BE)
- Inserm (FR)
- Institut National des Sciences Appliquées de Toulouse (FR)
- Université Côte d'Azur (FR)
- Université Paris Cité (FR)
- Université de Lille (FR)
- Université Paris Sciences et Lettres (FR)
- Institut Pasteur de Lille (FR)
- Institut Gustave Roussy (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Sorbonne Université (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Centre de Recherche des Cordeliers (FR)
- La Ligue Contre le Cancer (FR)
- Antwerp University Hospital (BE)
- Laboratoire d'Ingénierie des Systèmes Biologiques et des Procédés (FR)
- Centre Méditerranéen de Médecine Moléculaire (FR)
- Unité de recherche sur les maladies cardiovasculaires et métaboliques (FR)
- Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR)
- Structure fédérative de recherche Necker (FR)
- Université de Toulouse (FR)
- Institut Curie (FR)
Publication Details
- Journal
- EMBO Molecular Medicine
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1038/s44321-026-00553-y
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Institut National Du Cancer
- Association Française pour l'Etude du Foie
- HORIZON EUROPE Framework Programme
- European Research Council
- Labex Immuno-Oncology